NCT00320203View on ClinicalTrials.gov

Anecortave Acetate in Patients With Open-angle Glaucoma

PHASE2CompletedINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions
Open-angle Glaucoma
Interventions
DRUG

Anecortave Acetate Sterile Suspension, 6 mg/mL

Single injection, anterior juxtascleral depot (AJD)

DRUG

Anecortave Acetate Sterile Suspension, 30 mg/mL

Single injection, anterior juxtascleral depot (AJD)

DRUG

Anecortave Acetate Sterile Suspension, 60 mg/mL

Single injection, anterior juxtascleral depot (AJD)

OTHER

Anecortave Acetate Vehicle

Single injection, anterior juxtascleral depot (AJD)

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00320203 - Anecortave Acetate in Patients With Open-angle Glaucoma | Biotech Hunter | Biotech Hunter